Every 8-K that Concentrix (CNXC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow CNXC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CNXC filings page.
Concentrix Corporation adopted an Amended and Restated Executive Severance Plan effective July 23, 2026, replacing its prior Change of Control Severance Plan. The Board took this action after an annual review of executive compensation and input from an independent compensation consultant to align severance practices more closely with market practice.
For executive officers terminated without cause, disability, or death (including certain voluntary resignations for reduced salary or position or relocation) within two months before or 12 months after a change of control, severance shifts from 18–24 months of salary continuation based on the past three years’ compensation to a lump sum equal to two times base salary plus target bonus, less applicable withholding. The plan also introduces severance outside the change-of-control window equal to one times base salary plus target bonus, less withholding, and adds a “best-net” Section 280G cut-back provision.
Concentrix reported fiscal second quarter 2026 revenue of $2,462.5M, up 1.9% year over year, with constant currency growth of 0.6%. GAAP operating income fell to $95.4M and operating margin declined to 3.9% from 6.1%, reflecting higher costs and significant acquisition, integration and restructuring charges.
GAAP net income rose to $55.3M, up 31%, and diluted EPS increased to $0.86, while non-GAAP diluted EPS edged down to $2.63 from $2.70. Cash flow from operations reached a record second-quarter $257.9M, with adjusted free cash flow of $242.3M.
For full-year 2026, Concentrix expects reported revenue between $9.925B and $10.025B, implying constant currency growth of 0.25% to 1.25%, non-GAAP operating income of $1.20B–$1.23B, non-GAAP diluted EPS of $10.83–$11.18, and adjusted free cash flow of $630–$650M.
Concentrix Corporation reported a change in its Board of Directors tied to ownership conditions in an Investor Rights Agreement related to its September 2023 Webhelp acquisition. Groupe Bruxelles Lambert SA (GBL) previously had the right to nominate one director as long as it beneficially owned at least 50% of the Concentrix shares issued to it in that deal.
On April 29, 2026, GBL entered into a transaction that reduced its beneficial ownership below this Board Nomination Threshold. As a result, GBL’s nominee, Bilge Ogut, resigned from the Concentrix Board and its committees, effective immediately.
Concentrix Corporation reported results of its 2026 annual stockholder meeting. Stockholders approved an amendment to the Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan to increase the number of shares available for issuance thereunder by 3,700,000 shares.
They also elected nine directors for terms expiring at the 2027 annual meeting and ratified Ernst & Young LLP as independent registered public accounting firm for fiscal year 2026. In an advisory vote, stockholders approved the compensation of the company’s named executive officers.
Concentrix reported mixed first quarter 2026 results. Revenue rose to $2,500.4 million, up 5.4% year-on-year, but GAAP net income fell to $21.6 million from $70.3 million, with diluted EPS dropping to $0.33 from $1.04.
Non-GAAP diluted EPS declined more modestly to $2.61 from $2.79, and adjusted EBITDA decreased to $348.2 million from $374.2 million. Operating cash flow was a use of $83.2 million and adjusted free cash flow was a use of $144.6 million. The company paid a $0.36 dividend, repurchased about 1 million shares for $42.0 million, and guided to low single-digit constant-currency revenue growth and non-GAAP diluted EPS of $2.57–$2.69 for Q2 and $11.48–$12.07 for full-year 2026, with expected adjusted free cash flow of $630–$650 million.
Concentrix Corporation has amended its accounts receivable securitization facility to expand its borrowing capacity and extend its duration. The lending commitment under the facility increased from up to $700 million to up to $750 million, giving the company more flexibility to fund working capital secured by receivables.
The amendment also pushes the facility’s termination date from January 14, 2027 to March 20, 2028. Concentrix acts as servicer, with Concentrix Receivables, Inc. as borrower and PNC Bank, National Association as administrative agent, alongside other group agents and lenders.
Concentrix Corporation issued and sold $600,000,000 aggregate principal amount of 6.500% Senior Notes due 2029 in a registered public offering. The company used the net proceeds, together with other funds, to redeem $600 million of its 6.650% Senior Notes due August 2, 2026.
The new notes pay 6.500% interest semi-annually starting September 1, 2026 and mature on March 1, 2029. Their interest rate may be adjusted if Moody’s, S&P or Fitch change the notes’ debt rating. The notes are callable, with a make-whole call before February 1, 2029 and par redemption thereafter.
Concentrix Corporation is issuing $600 million of 6.500% Senior Notes due 2029 in a public offering under an effective shelf registration. The company has entered into an underwriting agreement led by BofA Securities and J.P. Morgan, with closing expected on February 24, 2026, subject to customary conditions.
Concentrix expects to use the net proceeds, together with other funds, to redeem or otherwise repay all or a portion of its 6.650% Senior Notes due August 2, 2026 and pay related fees and expenses. It has notified holders that $600 million of the currently outstanding $800 million aggregate principal amount of these 2026 Notes will be redeemed on February 24, 2026.
Concentrix Corporation filed a current report to let investors know it has released its financial results for the quarter and year ended November 30, 2025. The company reported these results through a press release dated January 13, 2026, which is included in the filing as Exhibit 99.1.
The company notes that this information is being furnished under the SEC’s Item 2.02 for results of operations and financial condition, meaning it is provided for disclosure purposes and is not treated as formally filed for liability purposes under certain securities laws.
Concentrix Corporation filed a current report stating that it has released its financial results for the third quarter ended August 31, 2025. The company issued a press release on September 25, 2025 to share details about its operations and financial condition for the period.
The press release is included as an exhibit to the report and is incorporated by reference into the results section, giving investors and analysts a central source for the company’s latest quarterly performance information.
Concentrix (Nasdaq: CNXC) filed an 8-K (Item 2.02) announcing it has released fiscal Q2 2025 results for the quarter ended May 31 2025. The company furnished, but did not file, a press release (Exhibit 99.1) containing the detailed financial statements and commentary. No numerical data, guidance, or strategic commentary is included in the 8-K text itself. The disclosure is strictly limited to the existence of the press release and therefore carries limited information for investors without referencing Exhibit 99.1. The filing reconfirms that the information is considered "furnished," not "filed," preserving safe-harbor protections.